Laifual Delivers 80% Top-Line Growth and Margin Expansion in 1H 2026, Loss Narrows Ahead of Hong Kong Listing

Bulletin Express
09/28

Zhejiang Laifual Drive Co., Ltd. (Laifual) reported robust interim results for the six months ended 30 June 2026, underscored by rapid revenue growth, margin improvement and a sharper strategic focus on humanoid-robot drive components.

Revenue and Profitability • Revenue surged 80.10 % year on year to RMB 142.21 million (USD 19.6 million). • Gross profit jumped 148.33 % to RMB 38.83 million, lifting gross margin to 27.3 % from 19.8 % a year earlier, reflecting product-mix optimisation and economies of scale from the new Shaoxing facility. • The period’s statutory net loss narrowed 14.1 % to RMB 71.87 million. On a non-IFRS basis, adjusted net loss reduced to RMB 4.12 million versus RMB 11.21 million a year ago. • Adjusted EBITDA swung to a positive RMB 12.40 million from RMB 0.28 million, while reported EBITDA loss shrank to RMB 55.35 million.

Operational Drivers • Harmonic reducers and precision components contributed 83.9 % of revenue, rising 82.0 % to RMB 119.36 million on a 112 % increase in shipment volume to 239,500 units. • Small-size reducers (≤ 52 mm), key for humanoid robots, doubled their share of shipments to 10.6 %. Unit cost fell to RMB 351 from RMB 482, expanding segment gross margin to 29.6 %. • Joint modules and robotic arms generated RMB 14.83 million (10.4 % of revenue); automated workstations added RMB 7.89 million.

Capacity Ramp-Up • The Shaoxing plant, commissioned in August 2025, reached a 95.1 % utilisation rate in 1H 2026, producing 256,900 reducers. Monthly designed capacity climbed to 64,800 units in July. • Capital expenditure totalled RMB 77.80 million, mainly for equipment and capacity expansion; target monthly capacity is 80,000 units by end-2026.

R&D and Intellectual Property • R&D spending rose 62.7 % to RMB 30.74 million, representing 21.6 % of revenue. • Patent portfolio expanded to 80 registered patents (51 invention patents). • R&D headcount reached 144, or 18.8 % of the workforce.

Balance Sheet and Liquidity • Cash, cash equivalents and FVPL investments totalled RMB 1.02 billion after the HK$1.09 billion IPO completed on 30 June 2026; proceeds remain unutilised at period-end. • Interest-bearing debt increased to RMB 300.80 million; gearing improved to 23.1 % (31 Dec 2025: –171.2 %) following derecognition of redemption liabilities post-IPO. • Net operating cash outflow was RMB 20.85 million; financing activities generated RMB 1.04 billion.

Strategic Outlook (Management Guidance) Management targets continuing capacity expansion, accelerated product iteration for lightweight, high-precision reducers and joint modules, deeper engagement with leading humanoid-robot customers, and measured international market entry. Outstanding harmonic-reducer orders exceeded 400,000 units as of 31 July 2026.

Corporate Developments • Laifual’s H-shares began trading on 30 June 2026; an additional 736,400 shares were issued on 27 July 2026 via partial over-allotment, raising a further HK$59.8 million. • The Board proposes a corporate name change; no interim dividend has been declared.

With a strengthened capital base and rapid market growth for precision transmission in humanoid and industrial robots, Laifual positions itself to capture accelerating demand while aiming to achieve sustained profitability.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10